Department for Work and Pensions

home

Site navigation


Prognosis and duration

In the rare situation where care and mobility needs are identified because of treatment of stage 1, 2 or 3 cervical cancer, the award should last for the duration of treatment as typically improvement is expected. If treatment side effects do not improve when treatment stops or develop some years later, disabling effects are likely to persist. In stage 4 and recurrent disease needs are likely to increase over time.

Cancer stage Award Period

Stages 1, 2 or 3

Period of treatment plus reasonable recovery period

Stage 4, and Recurrent disease

Indefinite award

All information must be taken into account when considering the duration of disabling effects and the duration of disabling effects must be based on the particular circumstances of the individual claimant.

Amended February 2009